Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Completed · Phase 2/Phase 3

Conditions studied: Hepatitis B

In brief

The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis B infection who are co-infected with HIV.

Key facts

Study ID

NCT00051038

Run by

Bristol-Myers Squibb

Starts

2002-09-01

Expected to finish

2005-10-01

Last updated by the study team

2011-04-14

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — New Haven, Connecticut, United States
• Local Institution — Altamonte Springs, Florida, United States
• Local Institution — Lousiville, Kentucky, United States
• Local Institution — Charlotte, North Carolina, United States
• Local Institution — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.